고관절 수술 환자에서 정맥혈전색전증의 예방

키워드

참고문헌 (18)

1. Blann AD, "Venous thromboembolism", BMJ, 332, pp.215~219 (2006)
2. Geerts WH, "American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines", Chest, 133(6), pp.381S~453S (2008)
3. Leizorovicz A, "SMART Study Group. Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study", J Thromb Haemost, 3, pp.28~34 (2005)
4. Piovella F, "AIDA investigators. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography", J Thromb Haemost, 3, pp.2664~2670 (2005)
5. Yoo MC, "Deep vein thrombosis after total hip arthroplasty in Korean patients and D-dimer as a screening tool", Arch Orthop Trauma Surg, 129, pp.887~894 (2009)
6. Kim YH, "John Charnley Award. Factors leading to low prevalence of DVT and pulmonary embolism after THA: analysis of genetic and prothrombotic factors", Clin Orthop Relat Res, 465, pp.33~39 (2007)
7. Mont MA, "AAOS clinical practice guideline : preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty", J Am Acad Orthop Surg, 19, pp.777~778 (2011)
8. Falck-Ytter Y, "American College of Chest Physicians. Prevention of VTE in orthopedic surgery patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines", Chest, 141(2), pp.e278S~e325S (2012)
9. Park YS, "Guideline for the prophylaxis of venous thromboembolism in hip surgery patients", J Korean Orthop Assoc, 46, pp.95~98 (2011)
10. Lieberman JR, "Prevention of venous thromboembolic disease after total hip and knee arthroplasty", J Bone Joint Surg Am, 95, pp.1801~1811 (2013)
11. Pulmonary Embolism Prevention(PEP)Trial Collaborative Group, "Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin : Pulmonary Embolism Prevention(PEP)trial", Lancet, 355, pp.1295~1302 (2000)
12. Hirsh J, "Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety", Chest, 102(4), pp.337S~351S (1992)
13. Hirsh J, "Low molecular weight heparin", Blood, 79, pp.1~17 (1992)
14. Hull RD, "Extended out-ofhospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty : a systematic review", Ann Intern Med, 135, pp.858~869 (2001)
15. Petitou M, "The synthetic pentasaccharide fondaparinux : first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa", Semin Thromb Hemost, 28, pp.393~402 (2002)
16. Kakkar AK, "RECORD2 Investigators. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial", Lancet, 372, pp.31~39 (2008)
17. Wilke T, "Nonadherence in outpatient thromboprophylaxis after major orthopedic surgery : a systematic review", Expert Rev Pharmacoecon Outcomes Res, 10, pp.691~700 (2010)
18. Lieberman JR, "The new AAOS clinical practice guidelines on venous thromboembolic prophylaxis : how to adapt them to your practice", J Am Acad Orthop Surg, 19, pp.717~721 (2011)

관련 논문AI추천